Literature DB >> 30660503

Targeting Cancer through the Epigenetic Features of Telomeric Regions.

María Isabel Vaquero-Sedas1, Miguel Ángel Vega-Palas2.   

Abstract

The integrity of the chromatin associated with telomeric regions, which include telomeres and subtelomeres, is essential for telomeres function and cell viability. Whereas human subtelomeres are heterochromatic, telomeres are labeled with euchromatic marks like H4K20me1 and H3K27ac in most commonly studied human cell lines. The epigenetic marks of human telomeric regions influence oncogenic processes. Indeed, different drugs that decrease their genome-wide levels are currently being used or tested in specific cancer therapies. These drugs can challenge cancer by altering the function of key cellular proteins. However, they should also compromise oncogenic processes by modifying the epigenetic landscape of telomeric regions. We believe that studies of telomeric chromatin structure and telomeres dysfunction should help to design epigenetic therapies for cancer treatment.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; chromatin; epigenetics; humans; subtelomeres; telomeres

Mesh:

Substances:

Year:  2019        PMID: 30660503     DOI: 10.1016/j.tcb.2018.12.006

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  4 in total

1.  Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment.

Authors:  Aditi Qamra; Tsz Wai Chu; Mélanie Criqui; Monika Sharma; Julissa Tsao; Danielle A Henry; Dalia Barsyte-Lovejoy; Cheryl H Arrowsmith; Neil Winegarden; Mathieu Lupien; Lea Harrington
Journal:  Elife       Date:  2020-04-16       Impact factor: 8.140

Review 2.  Histone Modifications and the Maintenance of Telomere Integrity.

Authors:  Meagan Jezek; Erin M Green
Journal:  Cells       Date:  2019-02-25       Impact factor: 6.600

3.  Epigenetic Characteristics of Human Subtelomeres Vary in Cells Utilizing the Alternative Lengthening of Telomeres (ALT) Pathway.

Authors:  Shir Toubiana; Aya Tzur-Gilat; Sara Selig
Journal:  Life (Basel)       Date:  2021-03-26

4.  Assessing the Epigenetic Status of Human Telomeres.

Authors:  María I Vaquero-Sedas; Miguel A Vega-Palas
Journal:  Cells       Date:  2019-09-07       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.